Document is current
Any future updates will be listed below
-
Authors
Varidel, Mathew
Hickie, Ian B.
Prodan, Ante
Skinner, Adam
Marchant, Roman
Cripps, Sally
Oliveria, Rafael
Chong, Min K.
Scott, Elizabeth
Scott, Jan
Iorfino, Frank
-
Funding
Funding for this research was provided by:
Medical Research Future Fund (MRFAI000097)
National Health and Medical Research Council (511921, GNT2018157)
- License Information
-
More Information
Article History
Received: 24 October 2023
Accepted: 25 April 2024
First Online: 7 June 2024
Competing interests
: I.B.H. is the Co-Director, Health and Policy at the Brain and Mind Centre (BMC) The University of Sydney. The BMC operates an early-intervention youth service at Camperdown under contract to Headspace. He is the Chief Scientific Advisor to, and a 3.2% equity shareholder in, InnoWell Pty Ltd, which supports the transformation of mental health services internationally through the use of innovative technologies. E.S. is a Principal Research Fellow at the Brain and Mind Centre The University of Sydney. She is a Discipline Leader of Adult Mental Health, the School of Medicine, University of Notre Dame, and a Consultant Psychiatrist. She was the Medical Director, of the Young Adult Mental Health Unit, St Vincent’s Hospital Darlinghurst until January 2021. She has received honoraria for educational seminars related to the clinical management of depressive disorders supported by Servier, Janssen and Eli-Lilly Pharmaceuticals. She has participated in a national advisory board for the antidepressant compound Pristiq, manufactured by Pfizer. She was the National Coordinator of an antidepressant trial sponsored by Servier.
